Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥1.2bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥2.4bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥1.1bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥94m2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥116m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥120m2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥352m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥131m2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥119m2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥131m2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥82m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥340m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥113m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥82m2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥113m2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥4.4bnat 2022-09-30Cons.Assets
Total assets¥4.6bnat 2022-03-31Cons.Assets
Total assets¥4.1bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥1.1bnat 2022-09-30Cons.Liabilities
Total liabilities¥1.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥3.3bnat 2022-09-30Cons.Net assets
Net assets / equity¥3.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥3.0bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥1.9bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥2.2bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥1.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.2bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.7bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow−¥191m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥659m2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥295m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥19m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥66m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥37m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥130m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥72m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥66m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥60.112022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥73.992022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥248.752021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥82.612021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥802021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio74.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.9%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥556m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥556m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥48m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥335m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥335m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥103m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2022-04-01 → 2022-09-30¥288m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2022-04-01 → 2022-09-30¥288m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2022-04-01 → 2022-09-30¥84m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥1.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥234m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥530m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥530m
jpcrp040300-q2r_E02021-000Healthcare Related Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥100m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥321m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥321m
jpcrp040300-q2r_E02021-000Optical Applications And Special Customized Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥84m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue2021-04-01 → 2021-09-30¥257m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentrevenue external2021-04-01 → 2021-09-30¥257m
jpcrp040300-q2r_E02021-000X Ray Residual Stress Analyzerreportable segmentsegment profit2021-04-01 → 2021-09-30¥78m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥1.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥262m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 420
ItemContextValueUnit
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember334690000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1178700000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember-JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E02021-000HealthcareRelatedProductsReportableSegmentMember-JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember-JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember-JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember287754000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E02021-000HealthcareRelatedProductsReportableSegmentMember556255000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember334690000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1178700000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E02021-000XRayResidualStressAnalyzerReportableSegmentMember83816000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E02021-000HealthcareRelatedProductsReportableSegmentMember47595000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E02021-000OpticalApplicationsAndSpecialCustomizedProductsReportableSegmentMember102744000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember234155000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)東海財務局長
Filing date cover pageFilingDateInstant2022-11-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第54期第2四半期(自 2022年7月1日 至 2022年9月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)パルステック工業株式会社
Company name in english cover pageFilingDateInstantPULSTEC INDUSTRIAL CO.,LTD.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長  鈴木 幸博
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)静岡県浜松市北区細江町中川7000番地の35
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)053-522-5176(直通)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役管理部長  工藤 孝史
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)静岡県浜松市北区細江町中川7000番地の35
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)053-522-5176(直通)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役管理部長  工藤 孝史
Place for public inspection cover page (text)FilingDateInstantText · Plus
Footnotes cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE02021
Fund codeFilingDateInstant-
Security codeFilingDateInstant68940
Filer name in japaneseFilingDateInstant
Original text (Japanese)パルステック工業株式会社
Filer name in englishFilingDateInstantPULSTEC INDUSTRIAL CO.,LTD.
Fund name in japaneseFilingDateInstant-
Fund name in englishFilingDateInstant-
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant-
Current fiscal year start dateFilingDateInstant2022-04-01
Current period end dateFilingDateInstant2022-09-30
Type of current periodFilingDateInstantQ2
Current fiscal year end dateFilingDateInstant2023-03-31
Previous fiscal year start dateFilingDateInstant2021-04-01
Comparative period end dateFilingDateInstant2021-09-30
Previous fiscal year end dateFilingDateInstant2022-03-31

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass